Yugal Goel

Molecular docking studies of 3-bromopyruvate and its derivatives to metabolic regulatory enzymes: Implication in designing of novel anticancer therapeutic strategies

Saveg Yadav, Shrish Kumar Pandey, Vinay Kumar Singh et al. · PLoS ONE · 2017 · 92 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Molecular docking of anti-inflammatory drug diclofenac with metabolic targets: Potential applications in cancer therapeutics

Shrish Kumar Pandey, Saveg Yadav, Yugal Goel et al. · Journal of Theoretical Biology · 2019 · 37 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Glutor, a Glucose Transporter Inhibitor, Exerts Antineoplastic Action on Tumor Cells of Thymic Origin: Implication of Modulated Metabolism, Survival, Oxidative Stress, Mitochondrial Membrane Potential, pH Homeostasis, and Chemosensitivity

Mithlesh Kumar Temre, Saveg Yadav, Yugal Goel et al. · Frontiers in Oncology · 2022 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Protective and recuperative effects of 3-bromopyruvate on immunological, hepatic and renal homeostasis in a murine host bearing ascitic lymphoma: Implication of niche dependent differential roles of macrophages

Saveg Yadav, Shrish Kumar Pandey, Yugal Goel et al. · Biomedicine & Pharmacotherapy · 2018 · 16 citations

Life Sciences, Immunology, Oncology +17

Antitumor action of 3-bromopyruvate implicates reorganized tumor growth regulatory components of tumor milieu, cell cycle arrest and induction of mitochondria-dependent tumor cell death

Saveg Yadav, Praveen Kumar Kujur, Shrish Kumar Pandey et al. · Toxicology and Applied Pharmacology · 2017 · 15 citations

Medicine, Cancer Biology, Oncology +17